Keros Therapeutics (KROS) FCF Margin (2019 - 2026)
Keros Therapeutics (KROS) recorded FCF Margin of -7123.64% in Q4 2025, down 5601.71 percentage points from -1521.93% a year earlier and down 7145.49 percentage points from the prior quarter.
Powered by 
Analysis
Keros Therapeutics (KROS) FCF Margin (2019 - 2026) Analysis & Trends
For FY2025, Keros Therapeutics reported FCF Margin of 43.41%, up 4629.33 percentage points from FY2024.
- Annual FCF Margin has a four-year change of +357.70 percentage points (FY2021 to FY2025).
- Across earlier years, FCF Margin came in at -4585.92% in FY2024 (+79501.50 pp), -84087.42% in FY2023 and -314.29% in FY2021.
- The Q4 2025 figure is the lowest quarterly FCF Margin since Q3 2024.
- On a year-over-year basis, FCF Margin rose in five of the last six quarters, with an average year-over-year change of +100978.94 percentage points.
- Per Business Quant, the preceding three quarters came in at 21.86% (Q3 2025), -167.01% (Q2 2025) and 76.03% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | Keros Therapeutics | 185.02 Mn | -900.96 Mn | - | 8.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 8.33% |
| Mar 31, 2026 | -981.47% |
| Dec 31, 2025 | -7,123.64% |
| Sep 30, 2025 | 21.86% |
| Jun 30, 2025 | -167.01% |
| Mar 31, 2025 | 76.03% |
| Dec 31, 2024 | -1,521.93% |
| Sep 30, 2024 | -7,960.31% |
| Jun 30, 2024 | -108,408.11% |
| Mar 31, 2024 | -54,826.51% |
| Dec 31, 2023 | -18,181.82% |
| Sep 30, 2023 | -431,650.00% |
| Mar 31, 2022 | -8.74% |
| Dec 31, 2021 | -98.62% |
| Jun 30, 2021 | -18,147.00% |
| Dec 31, 2019 | -220.64% |
| Sep 30, 2019 | -121.48% |
| Jun 30, 2019 | -208.12% |
| Mar 31, 2019 | -100.52% |
API Access
Keros Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();